From Medscape Pulmonary Medicine

Coverage from the

European Respiratory Society (ERS) International Congress 2016

September 03 - 07, 2016; London, United Kingdom

September 03 - 07, 2016 London, United Kingdom

ERS Vitamin D Eases Asthma, Cochrane Review Finds After vitamin D supplementation, asthma patients experience fewer severe exacerbations and medical emergencies, researchers report, but questions remain.
Medscape Medical News, September 8, 2016
ERS Endobronchial Valve Has IMPACT on Homogeneous Emphysema Treatment options are limited for patients with homogeneous emphysema, but an endobronchial valve can help, according to new research.
Medscape Medical News, September 8, 2016
ERS Injected Benralizumab Targets Eosinophils in Severe Asthma The age of precision medicine has arrived for a subset of asthma patients with an eosinophilic-driven phenotype, researchers report.
Medscape Medical News, September 6, 2016

Conference News

ERS Early Exposure to Antibiotics Augments Allergy, Eczema Risk
Medscape Medical News, September 9, 2016
ERS Elective Cesarean Birth and Childhood Asthma Risk
Medscape Medical News, September 9, 2016
ERS Vitamin D Eases Asthma, Cochrane Review Finds
Medscape Medical News, September 8, 2016
ERS Endobronchial Valve Has IMPACT on Homogeneous Emphysema
Medscape Medical News, September 8, 2016

ERS Team Approach Best to Detect Early COPD
Medscape Medical News, September 7, 2016
ERS Injected Benralizumab Targets Eosinophils in Severe Asthma
Medscape Medical News, September 6, 2016
ERS Major Trial: Forgo Whole-Brain RT in Lung Cancer
Medscape Medical News, September 4, 2016
ERS Pollution in the Air at ERS International Congress
Medscape Medical News, August 29, 2016

First Look: SAVE Presentation from ESC

SAVE: No CV Event Reduction With CPAP A randomized trial shows no reduction in cardiovascular events in patients with established coronary or cerebrovascular disease and obstructive sleep apnea from CPAP therapy.
Medscape Medical News, Aug 28, 2016

Popular News from ERS 2015

Pulmonary Fibrosis Treatment Trickier Than Drug Trials Imply In real-world patients with idiopathic pulmonary fibrosis, the mortality rate is higher than clinical trials have suggested, and disease is more severe, a German registry reveals.
Medscape Medical News, Oct 2, 2015
SUMMIT: No Mortality Benefit to Breo in COPD The hypothesis that the cardiovascular effects often seen in patients with COPD can be explained by a link between lung inflammation and systemic inflammation has been refuted in a new study.
Medscape Medical News, Sep 11, 2015
After SUMMIT, Is It Downhill for Breo? Positive secondary outcomes hinting at efficacy in chronic obstructive pulmonary disease are prompting debate, and some believe that a longer trial might have been positive.
Medscape Medical News, Sep 30, 2015

Medscape Pulmonary Medicine© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Previous Coverage

Related Resources